• Sulfaphenazole, Perfusion, and Pressure Injury Repair

  2026-08-25

  Turner and colleagues show that sulfaphenazole can reduce pressure- and thermal-injury severity in an ischemia–reperfusion model, with rapid restoration of tissue perfusion as a central response. The work links vascular protection to improved wound closure, tissue strength, reduced hypoxia, and lower inflammatory and fibrotic remodeling, while also identifying important limits to translation beyond the animal model.

• AMD-070 hydrochloride: CXCR4 Workflow Guide

  2026-08-25

  Build reproducible migration, receptor-signaling, and HIV entry-inhibition assays with AMD-070 hydrochloride, a soluble small-molecule CXCR4 antagonist. This guide translates a tissue-perfusion study into practical experimental design while clearly separating validated evidence from forward-looking assay recommendations.

• O-propargyl-puromycin (OPP) Workflow Guide

  2026-08-24

  O-propargyl-puromycin (OPP) converts a brief translation pulse into a click-compatible signal for measuring newly synthesized proteins. This guide shows how to apply it to B-cell immunology, mitochondrial stress studies, imaging, flow cytometry, and proteomics while avoiding common normalization and interpretation errors.

• Sulfo-NHS-SS-Biotin: Cleavable Labeling Guide

  2026-08-24

  Sulfo-NHS-SS-Biotin enables aqueous, amine-selective labeling of proteins and intact-cell surfaces for reversible affinity capture. Its cleavable disulfide spacer is especially useful when researchers need to enrich surface proteins, release labeled material, or distinguish extracellular labeling from intracellular pools.

• Vasopressin Analogues: Multitasking Peptides

  2026-08-23

  Glavaš and colleagues review how structural modification of vasopressin reshapes receptor activity, stability, duration of action, and therapeutic use. The paper provides a useful framework for interpreting lypressin, desmopressin, terlipressin, and related peptides across endocrine, cardiovascular, and emerging antiviral research.

• BGJ398 Workflow for FGFR Signaling Research

  2026-08-22

  BGJ398 (NVP-BGJ398) combines strong FGFR1/2/3 activity with useful kinase selectivity for oncology research and pathway studies. This practical guide connects cancer-cell assays with a carefully qualified developmental-biology application inspired by comparative guinea pig and mouse data.

• SIRT1, Mitochondrial Biogenesis, and Prion Toxicity

  2026-08-22

  Zhao and colleagues identify a SIRT1–PGC-1α–TFAM axis that links mitochondrial biogenesis with neuronal injury caused by the prion peptide PrP106–126 in N2a cells. Their findings position SIRT1 activation, including resveratrol treatment, as a mechanistically testable strategy for restoring mitochondrial function and limiting apoptosis in a cellular prion model.

• L1023 Anti-Cancer Compound Library Workflow

  2026-08-21

  Turn a 1,164-compound oncology collection into a decision-ready workflow for phenotypic screening, resistance biology, and mechanism validation. This guide connects MCL1-focused apoptosis assays with broader pathway profiling, including BRAF and mTOR-oriented screens, while emphasizing plate quality, orthogonal confirmation, and practical troubleshooting.

• Hexa-Acylated LPS and Cancer Immunotherapy Response

  2026-08-20

  This Nature Microbiology study moves beyond taxonomic descriptions of the gut microbiome by identifying the acylation state of microbial lipopolysaccharide as a functional determinant of anti-PD-1 response. Human metagenomic analysis, immune assays, and mouse tumor experiments show that hexa-acylated LPS can enhance TLR4-dependent antitumor immunity, whereas hypo-acylated LPS may oppose it.

• KX2-391 dihydrochloride: Assay Guide

  2026-08-20

  A scenario-based guide to using KX2-391 dihydrochloride in cell viability, proliferation, cytotoxicity, HBV, and BoNT/A workflows. It explains how SKU A3535 supports concentration selection, solvent control, mechanism-aware interpretation, and practical product evaluation.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-19

  Learn how to apply tyramide-based fluorescence amplification to low-abundance targets in IHC, ICC, and ISH. This workflow connects the kit’s spatially retained signal to metastatic HNSCC research while providing practical setup, optimization, and troubleshooting guidance.

• Nelfinavir Mesylate: Applied Research Workflows

  2026-08-19

  Nelfinavir Mesylate supports both cell-based HIV-1 protease inhibition assays and mechanistic studies of DDI2–NFE2L1 control of ferroptosis. This guide translates its biochemical potency, formulation properties, and cross-domain use into practical workflows, controls, and troubleshooting decisions.

• Paroxetine Mesylate: Applied Research Workflows

  2026-08-18

  Paroxetine Mesylate supports a practical research strategy spanning SERT pharmacology, enzyme-interaction studies, kinase profiling, and colorectal cancer models. This guide translates its multi-target profile into assay setup, protocol parameters, comparative applications, and troubleshooting decisions.

• From PLAC1 Biology to Smarter Cancer Screening

  2026-08-18

  A translational framework for moving from PLAC1-associated biology in clear cell renal cell carcinoma to biomarker-aware chemical screening. The article explains how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) can support mechanism-focused hit discovery, orthogonal validation, pathway mapping, and more disciplined decisions about preclinical relevance.

• Lysosomal β-Galactosidase Staining in HNSCC

  2026-08-17

  Learn how the Lysosomal β-Galactosidase Staining Kit can strengthen senescence interpretation in HNSCC cisplatin-resistance studies. This guide connects lysosomal enzyme imaging with the SLC25A1–H3K27ac mechanism while clarifying controls, assay limits, and practical workflow decisions.

7915 records 1/528 page Next 12345 下5页 Last page